New Strategies for Targeting CTLA-4 Emerge
OncLive,
In 2011, the development of ipilimumab (Yervoy), a novel antibody targeting the CTLA-4 immune checkpoint, helped launch the…
In 2011, the development of ipilimumab (Yervoy), a novel antibody targeting the CTLA-4 immune checkpoint, helped launch the…
Share on PinterestThe Food and Drug administration has approved two AstraZeneca drugs for use in conjunction with chemotherapy…